Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard J Marek

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Topics in Behavioral Neurosciences|August 24, 2017
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal NeuronsGerard J Marek
Neuroscience Letters|May 20, 2008
Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administrationGerard J Marek
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2012
Activation of adenosine₁ receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in ratsGerard J Marek
European Journal of Pharmacology|August 12, 2003
Behavioral evidence for mu-opioid and 5-HT2A receptor interactionsGerard J Marek
Current Opinion in Pharmacology|March 17, 2004
Metabotropic glutamate 2/3 receptors as drug targetsGerard J Marek
European Journal of Pharmacology|April 8, 2010
Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognitionGerard J Marek
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2008
Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramineGerard J Marek
Current Pharmaceutical Design|June 6, 2015
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic EfficacyGerard J Marek
Neuropharmacology|March 28, 2009
Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in ratsGerard J Marek
International Review of Neurobiology|March 14, 2007
Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug developmentGerard J Marek
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Topics in Behavioral Neurosciences|August 24, 2017
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal NeuronsGerard J Marek
Neuroscience Letters|May 20, 2008
Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administrationGerard J Marek
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2012
Activation of adenosine₁ receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in ratsGerard J Marek
European Journal of Pharmacology|August 12, 2003
Behavioral evidence for mu-opioid and 5-HT2A receptor interactionsGerard J Marek
Current Opinion in Pharmacology|March 17, 2004
Metabotropic glutamate 2/3 receptors as drug targetsGerard J Marek
European Journal of Pharmacology|April 8, 2010
Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognitionGerard J Marek
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2008
Regulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramineGerard J Marek
Current Pharmaceutical Design|June 6, 2015
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic EfficacyGerard J Marek
Neuropharmacology|March 28, 2009
Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in ratsGerard J Marek
International Review of Neurobiology|March 14, 2007
Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug developmentGerard J Marek
Pageof 6